10-hydroxycarbamazepine has been researched along with fendiline in 1 studies
| Studies (10-hydroxycarbamazepine) | Trials (10-hydroxycarbamazepine) | Recent Studies (post-2010) (10-hydroxycarbamazepine) | Studies (fendiline) | Trials (fendiline) | Recent Studies (post-2010) (fendiline) |
|---|---|---|---|---|---|
| 106 | 20 | 30 | 156 | 16 | 31 |
| Protein | Taxonomy | 10-hydroxycarbamazepine (IC50) | fendiline (IC50) |
|---|---|---|---|
| Sphingomyelin phosphodiesterase | Homo sapiens (human) | 5.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Golbraikh, A; Grulke, CM; Hajjo, R; Huang, XP; Roth, BL; Setola, V; Tropsha, A | 1 |
1 other study(ies) available for 10-hydroxycarbamazepine and fendiline
| Article | Year |
|---|---|
Development, validation, and use of quantitative structure-activity relationship models of 5-hydroxytryptamine (2B) receptor ligands to identify novel receptor binders and putative valvulopathic compounds among common drugs.
Topics: Algorithms; Binding, Competitive; Databases, Factual; Dexfenfluramine; Drug-Related Side Effects and Adverse Reactions; Fenfluramine; Heart Valve Diseases; Ligands; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Radioligand Assay; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Agonists | 2010 |